RHO and medullary thyroid gland carcinoma: Rho activation is increased at the leading edge of MTLn3 cells (El-Sibai et al., 2007; El-Sibai et al., 2008), and inhibition of Rho activity in MTLn3 cells decreased ExoS translocation to levels similar to that of MTC cells.